Progressive and Reversible Conduction Disease With Checkpoint Inhibitors

Canadian Journal of Cardiology

Volumn 33, Issue 10, 2017, Pages 1335.e13-1335.e15

  Reddy, Neeti ^a   Moudgil, Rohit ^a   Lopez Mattei, Juan C ^a   Karimzad, Kaveh ^a   Mouhayar, Elie N ^a   Somaiah, Neeta ^a   Conley, Anthony P ^a   Patel, Shreyaskumar ^a   Giza, Dana E ^a   Iliescu, Cezar ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CREATINE KINASE MB; CYTOTOXIC T LYMPHOCYTE ASSOCIATED ANTIGEN 4 INHIBITOR; LIVER ENZYME; MYCOPHENOLATE MOFETIL; PROGRAMMED DEATH LIGAND 1 INHIBITOR; PROTEIN INHIBITOR; STEROID; TROPONIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; AGED; AKINESIA; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CASE REPORT; CLINICAL ARTICLE; COMPLETE HEART BLOCK; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART CATHETERIZATION; HEART CONDUCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HUMAN TISSUE; HYPERTRANSAMINASEMIA; HYPOKINESIA; MALE; MYOCARDITIS; PACEMAKER ELECTRODE; STEROID THERAPY; ADVERSE EFFECTS; BRUGADA SYNDROME; CHEMICALLY INDUCED; DISEASE COURSE; ELECTROCARDIOGRAPHY; IMMUNOTHERAPY; PATHOPHYSIOLOGY; SARCOMA;

AGED; ANTINEOPLASTIC AGENTS; BRUGADA SYNDROME; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; HUMANS; IMMUNOTHERAPY; MALE; SARCOMA;

EID: 85027419853     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2017.05.026     Document Type: Article

References (5)

1. Boutros, C., Tarhini, A., Routier, E., et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Nat Rev Clin Oncol 13 (2016), 473–486.
2. Johnson, D.B., Balko, J.M., Compton, M.L., et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375 (2016), 1749–1755.
3. Laubli, H., Balmelli, C., Bossard, M., et al. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. J Immunother Cancer, 3, 2015, 11.
4. Wang, J., Okazaki, I.M., Yoshida, T., et al. PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol 22 (2010), 443–452.
5. Tivol, E.A., Borriello, F., Schweitzer, A.N., et al. Loss of CTLA 4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3 (1995), 541–547.